| Filed On | Filing |
|---|---|
| 26 Oct 2023 |
8-K/A: Financial Statements and Exhibits
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248) |
| 16 May 2023 |
8-K/A: Financial Statements and Exhibits
On February 28, 2023, Xtant Medical Holdings, Inc., a Delaware corporation (“Xtant” or the “Company”), entered into an Equity Purchase Agreement (the “Equity Purchase Agreement”) with Surgalign SPV, Inc. (“Surgalign SPV”), a Delaware cor... |
| 15 May 2015 |
8-K/A: Regulation FD Disclosure
BELGRADE, Mont.—(BUSINESS WIRE) — May 15, 2015 — Bacterin International Holdings, Inc. (OTCQX: BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockhol... |
| 16 Oct 2014 |
8-K/A: Results of Operations and Financial Condition
Third Quarter total revenue in the range of $8.3 million to $8.5 million, an increase of approximately 4-7% over the same period last year. |
| 09 Sep 2014 |
8-K/A: Departure/Election of Directors or Officers; Compensation
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. |
| 22 Jul 2014 |
8-K/A: Results of Operations and Financial Condition
Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year. |
| 04 Oct 2010 |
8-K/A: Changes in Registrant's Certifying Accountant
We were previously the principal accountants for Bacterin International Holdings, Inc., formerly known as K-Kitz, Inc. (Commission File Number 333-158426) (the “Company”), and we issued our report dated March 17, 2010 on the financial st... |
Loading...